UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month ended March 2026
Commission File Number: 001-42907
Charming Medical Limited
(Translation of registrant’s name into English)
Units 1803-1806, 18/F, Hang Lung Centre
2-20 Paterson Street, Causeway Bay, Hong Kong
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
Charming Medical Limited (the “Company”) is hereby furnishing this Report on Form 6-K to provide its unaudited interim financial results for the six months ended September 30, 2025, which is furnished as Exhibit 99.1 to this Report on Form 6-K.
1
Exhibit Index
| Exhibit No. | Description | |
| 99.1 | Unaudited Interim Condensed Consolidated Financial Statements for the Six Months Ended September 30, 2025 and 2024 |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Charming Medical Limited | ||
| Date: March 31, 2026 | By: | /s/ Kit Wong |
| Name: | Kit Wong | |
| Title: | Chief Executive Officer and | |
| Chairman of the Board | ||
3